CS38191A2 - Eye-drops - Google Patents
Eye-drops Download PDFInfo
- Publication number
- CS38191A2 CS38191A2 CS91381A CS38191A CS38191A2 CS 38191 A2 CS38191 A2 CS 38191A2 CS 91381 A CS91381 A CS 91381A CS 38191 A CS38191 A CS 38191A CS 38191 A2 CS38191 A2 CS 38191A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- kapky
- primycin
- eye
- drops
- distilled water
- Prior art date
Links
- 239000003889 eye drop Substances 0.000 title claims description 5
- 229940012356 eye drops Drugs 0.000 title claims description 4
- NYWSLZMTZNODJM-MCGDBQAWSA-N 2-[5-[(4e,20e)-35-butyl-19-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine Chemical compound OC1CC(O)CC(O)CC(O)CC(O)CCCC\C(C)=C\C(C)C(C(C)C(O)CCCN=C(N)N)OC(=O)C(CCCC)C(O)C(C)CCC(O)CCCC(O)CCCC(O)\C(C)=C\C1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 NYWSLZMTZNODJM-MCGDBQAWSA-N 0.000 claims description 7
- 229950010664 primycin Drugs 0.000 claims description 7
- NYWSLZMTZNODJM-SDUQVVOESA-N primycin Natural products CCCC[C@H]1[C@H](O)[C@H](C)CC[C@@H](O)CCC[C@@H](O)CCC[C@@H](O)C(=C[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)C[C@H](O)C[C@@H](O)C[C@H](O)C[C@H](O)CCCCC(=C[C@@H](C)[C@@H](OC1=O)[C@H](C)[C@H](O)CCCNC(=N)N)C)C NYWSLZMTZNODJM-SDUQVVOESA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 2
- 229940072106 hydroxystearate Drugs 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001133165 Thermopolyspora Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU90808A HU207222B (en) | 1990-02-15 | 1990-02-15 | Process for producing eyedrops containing primycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS38191A2 true CS38191A2 (en) | 1991-09-15 |
Family
ID=10951455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS91381A CS38191A2 (en) | 1990-02-15 | 1991-02-14 | Eye-drops |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0474800B1 (es) |
| CN (1) | CN1054718A (es) |
| AU (1) | AU7210091A (es) |
| CA (1) | CA2058949A1 (es) |
| CS (1) | CS38191A2 (es) |
| DE (1) | DE69100987D1 (es) |
| ES (1) | ES2062764T3 (es) |
| FI (1) | FI920461A0 (es) |
| HU (1) | HU207222B (es) |
| IL (1) | IL97159A0 (es) |
| WO (1) | WO1991012008A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1057444C (zh) * | 1994-03-16 | 2000-10-18 | 吴生武 | 治疗近视眼药水 |
| SK164796A3 (en) | 1994-11-03 | 1997-06-04 | Dresden Arzneimittel | Novel cyclosporine preparation forms for oral administration of and process for producing them |
| DE19544507B4 (de) * | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
| SI0971707T1 (en) * | 1997-04-04 | 2003-04-30 | Human Oltoanyagtermel� es Gyogyszergyarto Rt. | Compositions for the treatment of burns and external ulcers and a process for the preparation thereof |
| FR2918891B1 (fr) | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
| CA2898644A1 (en) * | 2013-01-24 | 2014-07-31 | Rigel Pharmaceuticals, Inc. | Composition for ophthalmic administration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1340517A (en) * | 1969-12-01 | 1973-12-12 | Burton Parsons Chemicals Inc | Ophthalmic solution |
| GB1538903A (en) * | 1975-04-11 | 1979-01-24 | Nelson Res & Dev | Carrier for a topically applied physiologically active agent or cosmetic agent |
| HU173708B (hu) * | 1975-06-20 | 1979-07-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija geterokolloidnogo 18-arabinozil-2-n-butil-3,7,11,15,19,21,23,27,25,37-dekagidroksi-4,16,32,34,36-pentametil-tetrakona-16,32-dien-35-0-lakton-40-guanidiniumsul'fata |
| DE3104282A1 (de) * | 1981-02-07 | 1982-10-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára RT, 1045 Budapest | Synergistisch antimikrobiell wirksames therapeutisches praeparat und ein verfahren zu dessen herstellung |
| CA1274508A (en) * | 1984-05-31 | 1990-09-25 | Imre Szilagyi | Primycin components and process for the separation of the antibiotic complex |
| HU194493B (en) * | 1985-11-27 | 1988-02-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing primycin-containing colloidal basic gel and compositions comprising the same |
-
1990
- 1990-02-15 HU HU90808A patent/HU207222B/hu not_active IP Right Cessation
-
1991
- 1991-02-06 IL IL97159A patent/IL97159A0/xx unknown
- 1991-02-08 AU AU72100/91A patent/AU7210091A/en not_active Abandoned
- 1991-02-08 ES ES91903310T patent/ES2062764T3/es not_active Expired - Lifetime
- 1991-02-08 EP EP91903310A patent/EP0474800B1/en not_active Expired - Lifetime
- 1991-02-08 DE DE91903310T patent/DE69100987D1/de not_active Expired - Lifetime
- 1991-02-08 WO PCT/HU1991/000006 patent/WO1991012008A1/en not_active Ceased
- 1991-02-08 CA CA002058949A patent/CA2058949A1/en not_active Abandoned
- 1991-02-14 CS CS91381A patent/CS38191A2/cs unknown
- 1991-02-15 CN CN91101155.2A patent/CN1054718A/zh active Pending
-
1992
- 1992-02-03 FI FI920461A patent/FI920461A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2062764T3 (es) | 1994-12-16 |
| FI920461A0 (fi) | 1992-02-03 |
| DE69100987D1 (de) | 1994-02-24 |
| CA2058949A1 (en) | 1991-08-16 |
| WO1991012008A1 (en) | 1991-08-22 |
| HU207222B (en) | 1993-03-29 |
| AU7210091A (en) | 1991-09-03 |
| CN1054718A (zh) | 1991-09-25 |
| HU900808D0 (en) | 1990-04-28 |
| HUT57047A (en) | 1991-11-28 |
| EP0474800B1 (en) | 1994-01-12 |
| IL97159A0 (en) | 1992-08-18 |
| EP0474800A1 (en) | 1992-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2565991T3 (es) | Composición terapéutica y uso | |
| DE69730621T3 (de) | Hydroalkoholische zusammensetzungen, die durch komplexe von grenzflächenaktiven verbindungen mit polymeren verdickt sind | |
| US3751562A (en) | Medicated gelled oils | |
| TWI640312B (zh) | 抗微生物之組成物及其製造方法 | |
| US2703777A (en) | Ophthalmological preparations and vehicles and method of making the same | |
| US2496270A (en) | Skin dressings with fugitive colors | |
| EP0136782A2 (en) | Chondroitin sulfate/sodium hyaluronate compositions | |
| US4224319A (en) | Antiseptic composition for topical application to the skin | |
| US4500510A (en) | Damaged fish tissue treating method and composition containing Aloe vera extract | |
| CS38191A2 (en) | Eye-drops | |
| US5778886A (en) | Vaginal compositions combining a spermicidal agent and a peroxygen compound | |
| PT91481A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo o sal de prata da sulfadiazina apropriadas para terapeutica externa local | |
| ES2234164T3 (es) | Formulaciones oftalmicas acuosas que comprenden quitosano. | |
| KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
| KR19990036340A (ko) | 글리세릴 폴리(메트)아크릴레이트형 젤을 베이스로 하는 제약학적 조성물 | |
| RU2233151C2 (ru) | Применение тозилхлорамидов для лечения заболеваний кожи и слизистой оболочки | |
| CN1899600B (zh) | 抗菌肽喷雾成膜剂及其制备方法 | |
| JP3472442B2 (ja) | 損傷皮膚修復用製剤 | |
| DK143537B (da) | Fremgangsmaade til fremstilling af en stabil vandig klar gelformig salve eller lotion indeholdende et steroid og et neomycinsalt | |
| ES2060029T3 (es) | Derivados de acido 6-fluorosiquimico. | |
| US2385262A (en) | Therapeutic-anesthetic preparations | |
| KR950006922B1 (ko) | 이박멸제 제조용 산 유도체 | |
| Narat | Brilliant green: A clinical study of its value as a local antiseptic | |
| CN117751948A (zh) | 一种复合消毒剂及其制备方法与应用 | |
| RU2188005C2 (ru) | Состав для антисептической обработки кожи рук и операционного поля |